Welcome to our dedicated page for SILICON LABORATORIES SEC filings (Ticker: SLAB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Silicon Laboratories Inc. filings document an operating semiconductor company focused on low-power wireless connectivity, embedded SoCs and security technology for edge devices. Its 8-K reports cover operating results, financial condition, non-GAAP measures, material-event disclosures, capital-structure items, material agreements and solicitation materials tied to shareholder matters.
Proxy and annual meeting filings disclose board elections, auditor ratification, executive compensation votes and amendments to the 2009 Stock Incentive Plan. The filings also identify the company’s Nasdaq-listed common stock and provide formal records of governance actions, equity-plan matters and stockholder voting outcomes.
Silicon Laboratories Inc. filed a current report to furnish a press release announcing its results of operations for its fiscal year and quarter ended January 3, 2026. The press release, attached as Exhibit 99, includes both GAAP and a broad set of non-GAAP financial measures.
The company explains that its non-GAAP metrics adjust for items such as stock compensation, intangible asset amortization, acquisition and disposition related items, termination costs and impairments, equity‑method investment adjustments, interest expense adjustments, and income tax adjustments based on a long-term 20% non-GAAP tax rate effective from the first quarter of 2024.
Silicon Laboratories states that reconciliations to the most directly comparable GAAP measures are provided in the press release and that the information in this report is furnished, not filed, and is not incorporated by reference into other SEC filings.
Silicon Laboratories Inc. agreed to be acquired by Texas Instruments in an all‑cash merger. Each share of Silicon Labs common stock will be converted at closing into the right to receive $231.00 in cash, with the company becoming a wholly owned TI subsidiary.
The Silicon Labs board unanimously approved the merger agreement and plans to recommend it to stockholders, who must still vote on the deal. Unvested and certain accelerated RSUs and PSUs will either vest and be paid in cash based on the $231 price or convert into TI stock units under similar terms. The parties expect closing in the first half of 2027, subject to stockholder approval, U.S. and foreign antitrust and investment clearances, and other customary conditions.
The agreement includes a no‑shop clause, mutual efforts covenants, and reverse and standard termination fees of $499 million for TI and $259 million for Silicon Labs under specified failure or superior‑proposal scenarios.
Silicon Laboratories director Nina Richardson reported a planned stock sale. On 01/13/2026, she sold 1,355 shares of Silicon Laboratories common stock at $149 per share, in an open-market transaction coded as a sale.
The filing notes that the shares were sold pursuant to Richardson's Rule 10b5-1 trading plan, which is a pre-arranged program for buying or selling stock. After this transaction, she beneficially owned 8,543 shares of Silicon Laboratories common stock directly.
A holder has filed a Notice of Proposed Sale of Securities under Rule 144 covering the planned sale of 1,355 shares of common stock through Fidelity Brokerage Services LLC on the NASDAQ exchange. The filing lists an aggregate market value of 201,895.00 for these shares and an approximate sale date of 01/13/2026.
The shares to be sold were acquired on 04/21/2021 through restricted stock vesting from the issuer as compensation. The filing also notes that the number of shares outstanding is 32,852,942; this is a baseline figure, not the amount being sold.
Silicon Laboratories (SLAB) reported an insider purchase by its Sr VP WW Sales & Marketing, Brandon Tolany. On 10/31/2025, he acquired 53 shares of common stock at $86.46 per share through the company’s Employee Stock Purchase Plan, a transaction coded “A.”
Following this purchase, his beneficial ownership stands at 62,381 shares, held directly.
Silicon Laboratories (SLAB) reported stronger Q3 results as demand recovered. Revenue rose to $205.999 million from $166.395 million, and gross margin improved to 57.8%. Operating loss narrowed to $12.342 million from $29.708 million, and net loss improved to $9.936 million from $28.504 million. Industrial & Commercial revenue reached $117.614 million, while Home & Life delivered $88.385 million.
Year‑to‑date revenue was $576.558 million vs. $418.137 million. Cash, cash equivalents and short‑term investments totaled $439.0 million, with operating cash flow of $87.358 million for the nine‑month period. Inventory declined to $82.190 million (85 DOI) and DSO was 29 days. The company had no borrowings under its $400 million revolver and was in covenant compliance. As of October 28, 2025, 32,852,942 common shares were outstanding. The Norwegian Tax Appeals Board decided in the company’s favor regarding a 2013 tax assessment.
Silicon Laboratories Inc. furnished an 8-K announcing it issued a press release with results for its fiscal quarter ended October 4, 2025. The press release is included as Exhibit 99.
The company highlights use of non-GAAP measures—such as non-GAAP gross margin, operating income (loss), net income (loss), and diluted EPS—with reconciliations to GAAP provided in the press release. Effective from the first quarter of 2024, a long-term 20% non-GAAP tax rate is applied to non-GAAP income before taxes. The information is furnished, not filed, and is not incorporated by reference.
Brandon Tolany, Senior Vice President Worldwide Sales & Marketing of Silicon Laboratories Inc. (SLAB), reported insider transactions dated 08/29/2025. The filing shows the exercise of a non-qualified stock option with a $43.82 exercise price that resulted in acquisition of 1,800 common shares, and a contemporaneous disposition of 1,800 common shares sold at $133.57. After the reported non-derivative transactions the filing lists beneficial ownership amounts of 64,128 and 62,328 shares following each reported non-derivative line, and Table II reports 6,200 derivative securities beneficially owned following the option transactions. The form is filed individually and signed on behalf of the reporting person.
Form 144 filing for Silicon Laboratories, Inc. (SLAB) documents a proposed sale of 1,800 common shares through Fidelity Brokerage Services on 08/29/2025 with an aggregate market value of $240,426.18. The filing states the shares were acquired via an option granted 01/28/2016 and payment is by cash. The issuer's reported number of shares outstanding is 32,815,310. The filer, identified by name in past sales, sold 2,270 shares on 08/19/2025 for $301,206.53 and 8,000 shares on 08/22/2025 for $1,161,817.60. The notice includes the required representation that the seller is not aware of undisclosed material adverse information.
Silicon Laboratories Inc. director and Senior Vice President WW Sales & Marketing Brandon Tolany reported transactions on 08/22/2025 involving 8,000 common shares acquired and 8,000 common shares sold. Tolany exercised 8,000 non-qualified stock options with an exercise price of $43.82 per share and acquired 8,000 shares. Those same 8,000 shares were sold the same day at a weighted average price of $145.23, with individual sale prices ranging between $145.13 and $145.36. Following these transactions, Tolany’s reported beneficial ownership decreased from 70,328 shares to 62,328 shares. The Form 4 is a single-person filing and includes a handwritten signature date of 08/22/2025 by Saie-Yau Hui for Brandon Tolany.